chr1-65621473-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002303.6(LEPR):​c.2597+15G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00358 in 1,605,308 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 97 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 71 hom. )

Consequence

LEPR
NM_002303.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.286

Publications

0 publications found
Variant links:
Genes affected
LEPR (HGNC:6554): (leptin receptor) The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010]
LEPR Gene-Disease associations (from GenCC):
  • obesity due to leptin receptor gene deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-65621473-G-C is Benign according to our data. Variant chr1-65621473-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 804989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.061 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LEPRNM_002303.6 linkc.2597+15G>C intron_variant Intron 18 of 19 ENST00000349533.11 NP_002294.2 P48357-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LEPRENST00000349533.11 linkc.2597+15G>C intron_variant Intron 18 of 19 1 NM_002303.6 ENSP00000330393.7 P48357-1

Frequencies

GnomAD3 genomes
AF:
0.0185
AC:
2808
AN:
152042
Hom.:
97
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0630
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00890
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00501
AC:
1254
AN:
250494
AF XY:
0.00354
show subpopulations
Gnomad AFR exome
AF:
0.0649
Gnomad AMR exome
AF:
0.00328
Gnomad ASJ exome
AF:
0.00288
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000335
Gnomad OTH exome
AF:
0.00279
GnomAD4 exome
AF:
0.00201
AC:
2927
AN:
1453148
Hom.:
71
Cov.:
28
AF XY:
0.00182
AC XY:
1314
AN XY:
723564
show subpopulations
African (AFR)
AF:
0.0635
AC:
2113
AN:
33272
American (AMR)
AF:
0.00439
AC:
196
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
0.00296
AC:
77
AN:
26032
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39496
South Asian (SAS)
AF:
0.000163
AC:
14
AN:
86080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53044
Middle Eastern (MID)
AF:
0.00696
AC:
40
AN:
5748
European-Non Finnish (NFE)
AF:
0.000174
AC:
192
AN:
1104818
Other (OTH)
AF:
0.00491
AC:
295
AN:
60038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
145
290
434
579
724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0185
AC:
2814
AN:
152160
Hom.:
97
Cov.:
32
AF XY:
0.0175
AC XY:
1299
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0630
AC:
2613
AN:
41492
American (AMR)
AF:
0.00889
AC:
136
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
67992
Other (OTH)
AF:
0.0104
AC:
22
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
138
276
414
552
690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00268
Hom.:
1
Bravo
AF:
0.0217
Asia WGS
AF:
0.00260
AC:
10
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 23, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Obesity due to leptin receptor gene deficiency Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.9
DANN
Benign
0.38
PhyloP100
-0.29
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6693573; hg19: chr1-66087156; API